Liang Lei, Song Haifeng, Ma Binglei, Zhang Zhenan, Zhu Kun, Li Qinhan, Zhou Chaohui, Li Aolin, Liu Jun, Zhang Quan, Zhu Shiyu, Zhang Qian
Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
Department of Urology, Beijing Tsinghua Changgung Hospital, Beijing, China.
Transl Androl Urol. 2021 Feb;10(2):548-554. doi: 10.21037/tau-20-1122.
Primitive neuroectodermal tumor (PNET) is a rare kind of sarcoma that is primarily found in the kidney and has a very poor prognosis. Here, we review and summarize the clinical data of patients with renal PNET in our center and follow up the patients for survival status. Although the current literature suggests that chemotherapy may benefit the survival of these patients, the information from our center suggests that this may not be the case.
We retrospectively analyzed the clinical data of patients with renal PNET diagnosed pathologically at Peking University First Hospital from January 1, 2007, to January 1, 2018. All of the patients were followed up for survival status.
Seven patients with renal PNET were found. The ratio of males to females was 6:1. The median age was 29 years (21-72 years) at the time of diagnosis. The preoperative imaging examination showed a large renal mass protruding outwards from the renal contour, with internal necrosis and hemorrhage. Six/7 patients were diagnosed with distant metastasis or retroperitoneal lymph node metastasis. The main clinical manifestations of patients were pain (5/7) and fever (3/7). In immunohistochemistry, all patients' samples were CD99 positive. All patients died in our follow-up, with an average overall survival (OS) of 12.09 months (1.90-26.77 months).
As a rare renal tumor, renal PNET has a propensity to occur in young males. Most patients have distant metastasis when they are diagnosed, and the prognosis is very poor. Effective treatments are urgently needed.
原始神经外胚层肿瘤(PNET)是一种罕见的肉瘤,主要发生于肾脏,预后很差。在此,我们回顾并总结了本中心肾PNET患者的临床资料,并对患者的生存状况进行随访。尽管目前的文献表明化疗可能有益于这些患者的生存,但来自本中心的信息表明情况可能并非如此。
我们回顾性分析了2007年1月1日至2018年1月1日在北京大学第一医院经病理诊断为肾PNET患者的临床资料。所有患者均进行了生存状况随访。
共发现7例肾PNET患者。男女比例为6:1。诊断时的中位年龄为29岁(21 - 72岁)。术前影像学检查显示肾脏有一个大肿块从肾轮廓向外突出,内部有坏死和出血。6/7的患者被诊断为远处转移或腹膜后淋巴结转移。患者的主要临床表现为疼痛(5/7)和发热(3/7)。免疫组化检查中,所有患者样本的CD99均呈阳性。在我们的随访中,所有患者均死亡,平均总生存期(OS)为12.09个月(1.90 - 26.77个月)。
作为一种罕见的肾脏肿瘤,肾PNET倾向于发生在年轻男性中。大多数患者在诊断时已有远处转移,预后很差。迫切需要有效的治疗方法。